Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma

SPISAROVÁ, M., B. MELICHAR, D. VITÁSKOVÁ, H. ŠTUDENTOVÁ
Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma. Future Oncology. 2020, 17(3), 241-254, ISSN: 1479-6694, PMID: 33016119,